Pfizer Total Current Liabilities 2012-2026 | PFE

Pfizer total current liabilities for the quarter ending March 31, 2026 were $36.596B, a 15.31% decline year-over-year.

  • Pfizer total current liabilities for 2024 were $42.995B, a 10.04% decline from 2023.
  • Pfizer total current liabilities for 2023 were $47.794B, a 13.42% increase from 2022.
  • Pfizer total current liabilities for 2022 were $42.138B, a 1.25% decline from 2021.

Pfizer Total Current Liabilities 2012-2026 | PFE

  • Pfizer total current liabilities for 2024 were $42.995B, a 10.04% decline from 2023.
  • Pfizer total current liabilities for 2023 were $47.794B, a 13.42% increase from 2022.
  • Pfizer total current liabilities for 2022 were $42.138B, a 1.25% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B